Teamwork Financial Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,718
Closed -$200K 303
2021
Q3
$200K Sell
1,718
-1,075
-38% -$163K 0.04% 260
2021
Q2
$620K Sell
2,793
-298
-10% -$58K 0.13% 131
2021
Q1
$409K Sell
3,091
-6,817
-69% -$1.08M 0.1% 160
2020
Q4
$1.71M Buy
+9,908
New +$1.36M 0.41% 40
2020
Q3
Sell
-3,598
Closed -$213K 202
2020
Q2
$213K Buy
+3,598
New +$237K 0.08% 172

Other funds holding NVCR

Teamwork Financial Advisors's NVCR Position: Q4 2021 in Review

Teamwork Financial Advisors sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 1,718 shares — an estimated $200K sold.

Teamwork Financial Advisors first reported a position in NVCR in Q2 2020 and held it in 5 quarters. The position peaked at $1.71M in Q4 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Teamwork Financial Advisors reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Teamwork Financial Advisors sold 1,718 NovoCure shares in Q4 2021, an estimated $200K.
  • Teamwork Financial Advisors first reported a position in NovoCure in Q2 2020 and held it in 5 quarters.
  • Teamwork Financial Advisors's NovoCure position peaked at $1.71M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Teamwork Financial Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.